Impact of COVID-19 on vascular patients worldwide: analysis of the COVIDSurg data
Louise Hitchman, Graeme Ambler, Matthew Machin, Ruth Benson, Panagiota Birmpili, Robert Blair, David Bosanquet, Nikesh Dattani, George Dovell, Rachael Forsythe, Brenig Gwilym, Sandip Nandhra, Sarah Onida, Ryan Preece, Joseph S Salim, Thanos Saratzis, Joseph Shalhoub, Aminder Singh, Leah Argus, Aneel Bhangu, Daoud Chaudhry, Brett E Dawson, James C Glasbey, Rohan R Gujjuri, Conor S Jones, Sivesh K Kamarajah, Chetan Khatri, James M Keatley, Samuel Lawday, Elizabeth Li, Harvinder Mann, Ella J Marson, Kenneth A McLean, Dmitri Nepogodiev, Maria Picciochi, Kwabena Siaw-Acheampong, Joana F Simoes, Elliott H Taylor, Abhinav Tiwari, Isobel M Trout, Mary L Venn, Richard J Wilkin, Tom E Abbott, Sadi Abukhalaf, Adesoji Ademuyiwa, Ahmed Adil, Arnav Agarwal, Felix Aigner, Zainab Al Balushi, Hamza Al Naggar
The COVIDSurg collaborative was an international multicenter prospective analysis of perioperative data from 235 hospitals in 24 countries. It found that perioperative COVID-19 infection was associated with a mortality rate of 24%. At the same time, the COVER study demonstrated similarly high perioperative mortality rates in vascular surgical patients undergoing vascular interventions even without COVID-19, likely associated with the high burden of comorbidity associated with vascular patients. This is a vascular subgroup analysis of the COVIDSurg cohort
Article, 2021